Dupixent Lawsuit Dupixent lawsuits are being investigated for patients who developed rare blood cancers such as cutaneous T-cell lymphoma (CTCL) after receiving injections, alleging that Sanofi and Regeneron failed to warn about the potential risks of immune suppression and delayed cancer diagnosis.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Sports Betting Addiction Lawsuit Sports betting addiction lawsuits are being investigated for college students and young adults who developed gambling problems after using apps like FanDuel and DraftKings, alleging that the platforms failed to warn about the addictive nature of their features and marketing practices.
Tabletop Fire Pit Lawsuit Individuals who suffered severe burns, or families who lost a loved one in a tabletop fire pit explosion, may be eligible for financial compensation through a fire pit injury lawsuit.
Ocaliva Lawsuit Ocaliva lawsuits are being investigated for users who experienced liver failure, cirrhosis progression, transplant, or death after taking the drug, alleging that Intercept Pharmaceuticals failed to warn about the risk of dosing toxicity and accelerated liver damage.
Andexxa Lawsuit Andexxa recall lawsuits are being investigated after the FDA linked the drug to an increased risk of thrombotic events, including stroke, heart attack, pulmonary embolism, and fatal blood clots.
ByHeart Formula Recall Lawsuit Parents are now filing ByHeart recall lawsuits alleging that contaminated infant formula caused botulism and other serious illnesses after the company failed to prevent or warn about dangerous manufacturing lapses.
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Roblox Lawsuit Families are filing Roblox lawsuits after children were targeted by predators for grooming, sextortion, sexual abuse, or exploitation on the platform. Learn who qualifies, what cases allege, and how to file a confidential claim.
Prescription Monitoring Had Little Effect On Opioid Deaths: Study May 9, 2018 Martha Garcia Add Your Comments While efforts are being made nationwide to help reduce the mis-use and abuse of opioid-based pain medications, new research suggests that monitoring patient prescriptions between doctors did not help reduce the number of overdose deaths. In a study published this week in the medical journal Annals of Internal Medicine, researchers from Columbia University indicate that fatal and non-fatal overdoses did not decrease among patients whose prescriptions for opioid painkillers were monitored, even between doctors. Prescription Drug Monitoring Programs (PDMP) are a part of the President’s Prescription Drug Abuse Prevention Program launched to prevent opioid drug abuse and overdoses. Do You Know about… SPORTS BETTING ADDICTION LAWSUITS FOR YOUNG ADULTS Gambling addiction and severe financial losses have been linked to popular sports betting platforms like DraftKings, FanDuel, and Caesars. Lawsuits are being filed by young adults and students who were targeted by deceptive promotions, addictive app features, and aggressive marketing tactics. See if you qualify for a sports betting addiction lawsuit. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Do You Know About… SPORTS BETTING ADDICTION LAWSUITS FOR YOUNG ADULTS Gambling addiction and severe financial losses have been linked to popular sports betting platforms like DraftKings, FanDuel, and Caesars. Lawsuits are being filed by young adults and students who were targeted by deceptive promotions, addictive app features, and aggressive marketing tactics. See if you qualify for a sports betting addiction lawsuit. Learn More SEE IF YOU QUALIFY FOR COMPENSATION The programs offer doctors access to prescription data statewide, so they can see if patients are receiving prescriptions of the same kind from other doctors. However, programs vary from state to state. One study estimated 75% of Medicare patients who took opioids receive opioid prescriptions from more than one doctor. Researchers set out to examine how effective this new program is in helping to identify patients who are using prescriptions from multiple doctors and if this reduced overdoses. The study analyzed 2,661 records from 17 studies using data from all 50 states and the District of Columbia. They used data for fatal and non-fatal opioid overdoses in states after PDMPs were implemented, beginning 1999 through 2016. The data indicates that the results were inconsistent, and there was no clear evidence that the monitoring programs help to reduce narcotic painkiller abuse or overdoses. However, there was “low strength evidence” from 10 studies indicating a marginal reduction in fatal overdoses. Of the studies that focused on fatal overdoses, three studies showed a decrease in overdose deaths. However, one study showed an increase in overdose deaths. Six studies showed no change at all. Among the studies that focused on non-fatal overdoses, one study showed a decrease in overdoses after the monitoring program was implemented. However, two studies showed no change in non-fatal overdoses after the program was implemented. Furthermore, researchers noted once the programs were implemented a “substitute” effect occurred. This is when opioid addicts substitute another drug for narcotic painkillers once doctors caught on to the abuse using the monitoring data. Three of six studies showed an increase in heroin overdoses after drug monitoring programs were put in place. Researchers warned that when addicts lose access to one legal drug, they often turn to another illegal drug that is easier to get. But this often increases their risk of accidental overdose, as many illicit drugs are quite potent or laced with other lethal drugs, like fentanyl. The findings of this latest study appear to contradict earlier studies which showed that monitoring held promise. A 2016 study indicated a program focused on monitoring doctor prescribing of opioids helped to reduce painkiller prescriptions by 30%. However, some features of the programs did help to reduce abuse in some studies, but again, the results were inconsistent. Researchers said the features that were the most effective were mandatory doctor review of prescriptions before prescribing a drug to a patient, weekly updates of the database, doctor authorization to access user data statewide, and monitoring of scheduled drugs, like those used to treat high blood pressure or diabetes. Researchers also emphasized money and resources provided to the monitoring programs should be reevaluated, especially since the programs may not be offering the results health regulators hoped they would. “Evidence that PDMP implementation either increases or decreases nonfatal or fatal overdoses is largely insufficient, as is evidence regarding positive associations between specific administrative features and successful programs,” the researchers wrote. “Research is needed to identify a set of ‘best practices’ and complementary initiatives to address these consequences.” Written by: Martha Garcia Health & Medical Research Writer Martha Garcia is a health and medical research writer at AboutLawsuits.com with over 15 years of experience covering peer-reviewed studies and emerging public health risks. She previously led content strategy at The Blogsmith and contributes original reporting on drug safety, medical research, and health trends impacting consumers. Tags: Drug Abuse, Drug Overdose, Opioids More Lawsuit Stories Depo-Provera Brain Tumor Lawsuit To Be Prepared for Trial by December 2026 December 23, 2025 Link Between Gastroparesis and Ozempic, Other GLP-1 Medications To Be Reviewed by MDL Court in 2026 December 23, 2025 Hyundai Seat Collapse Lawsuit Filed Over Severe Spinal Injury in Rear-End Accident December 23, 2025 0 Comments CompanyThis field is for validation purposes and should be left unchanged.Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA Term Δ MORE TOP STORIES Depo-Provera Brain Tumor Lawsuit To Be Prepared for Trial by December 2026 (Posted: today) A federal judge has scheduled the first Depo-Provera brain tumor pilot trial to begin sometime in December 2026. MORE ABOUT: DEPO-PROVERA LAWSUITDepo-Provera Meningioma Warning Update Approved by FDA, As Lawsuits Move Forward (12/17/2025)Lawsuit Alleges Depo-Provera Neurological Symptoms Were Result of Meningioma (12/12/2025)Court To Weigh Evidence That Depo-Provera Causes Meningioma Tumors in Mid-2026 (12/08/2025) Amazon Fire Pit Lawsuit Set For Trial in February 2027 (Posted: yesterday) A federal judge has set a February 2027 trial date for an Amazon fire pit lawsuit alleging that a teenager suffered severe burn injuries after a relative attempted to relight the device. MORE ABOUT: TABLETOP FIRE PIT LAWSUITFamily Dollar, Amazon Face Lawsuit Over Tabletop Fire Pit Burn Injuries (12/03/2025)Amazon Space Heater Lawsuit Claims Defective Device Caused First Degree Burns (11/24/2025)Amazon Tabletop Fire Pit Fuel Recall Issued Due to “Deadly Risk of Flash Fire”: CPSC (11/21/2025) Dupixent Cancer Lawsuit Filed Over Cutaneous T-Cell Lymphoma (CTCL) Diagnosis (Posted: 4 days ago) An Illinois woman diagnosed with stage IV cutaneous T-cell lymphoma (CTCL) after two years of Dupixent injections has filed a lawsuit against the drug manufacturers. MORE ABOUT: DUPIXENT LAWSUITLawyers Propose Dupixent Lawsuit Be Set for Trial After Dec. 6, 2027 (12/11/2025)Dupixent CTCL Lawsuit Filed Over Diagnosis of Both Mycosis Fungoides and Sezary Syndrome (12/05/2025)Drug Makers Must Respond to Dupixent Lawsuit Over Lymphoma Diagnosis by Jan. 7, 2026 (12/02/2025)
Link Between Gastroparesis and Ozempic, Other GLP-1 Medications To Be Reviewed by MDL Court in 2026 December 23, 2025
Depo-Provera Brain Tumor Lawsuit To Be Prepared for Trial by December 2026 (Posted: today) A federal judge has scheduled the first Depo-Provera brain tumor pilot trial to begin sometime in December 2026. MORE ABOUT: DEPO-PROVERA LAWSUITDepo-Provera Meningioma Warning Update Approved by FDA, As Lawsuits Move Forward (12/17/2025)Lawsuit Alleges Depo-Provera Neurological Symptoms Were Result of Meningioma (12/12/2025)Court To Weigh Evidence That Depo-Provera Causes Meningioma Tumors in Mid-2026 (12/08/2025)
Amazon Fire Pit Lawsuit Set For Trial in February 2027 (Posted: yesterday) A federal judge has set a February 2027 trial date for an Amazon fire pit lawsuit alleging that a teenager suffered severe burn injuries after a relative attempted to relight the device. MORE ABOUT: TABLETOP FIRE PIT LAWSUITFamily Dollar, Amazon Face Lawsuit Over Tabletop Fire Pit Burn Injuries (12/03/2025)Amazon Space Heater Lawsuit Claims Defective Device Caused First Degree Burns (11/24/2025)Amazon Tabletop Fire Pit Fuel Recall Issued Due to “Deadly Risk of Flash Fire”: CPSC (11/21/2025)
Dupixent Cancer Lawsuit Filed Over Cutaneous T-Cell Lymphoma (CTCL) Diagnosis (Posted: 4 days ago) An Illinois woman diagnosed with stage IV cutaneous T-cell lymphoma (CTCL) after two years of Dupixent injections has filed a lawsuit against the drug manufacturers. MORE ABOUT: DUPIXENT LAWSUITLawyers Propose Dupixent Lawsuit Be Set for Trial After Dec. 6, 2027 (12/11/2025)Dupixent CTCL Lawsuit Filed Over Diagnosis of Both Mycosis Fungoides and Sezary Syndrome (12/05/2025)Drug Makers Must Respond to Dupixent Lawsuit Over Lymphoma Diagnosis by Jan. 7, 2026 (12/02/2025)